DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS .3. INTESTINAL TRANSPORT OF VARIOUS VASOPRESSIN ANALOGS IN THE PRESENCE OF LYSOPHOSPHATIDYLCHOLINE

被引:12
作者
BRONDSTED, H [1 ]
NIELSEN, HM [1 ]
HOVGAARD, L [1 ]
机构
[1] ROYAL DANISH SCH PHARM,DEPT PHARMACEUT,DK-2100 COPENHAGEN O,DENMARK
关键词
DDAVP; VASOPRESSIN; INTESTINAL TRANSPORT; ABSORPTION ENHANCER; PHOSPHOLIPID; LYSOPHOSPHATIDYLCHOLINE; CACO-2; CELL CULTURE;
D O I
10.1016/0378-5173(94)00233-U
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The transport of a series of vasopressin and oxytocin analogues with varying lipophilicities was studied in Caco-2 monolayers. Transport was studied across the bare monolayer and after treatment with a phospholipid absorption enhancer, palmitoyl lysophosphatidylcholine. The range in lipophilicity of the analogues, estimated as the capacity factor, was found to be from 0.19 to 3.43. The intrinsic transport of the peptides across Caco-2 monolayers was found to be low. The apparent permeability coefficients, P-app were in the range of 2 x 10(-8)-6 x 10(-7) cm/s. However, peptide transport was significantly greater (P-app in the range of 5 x 10(-6)-2 x 10(-5) cm/s) when facilitated by addition of palmitoyllysaphosphatidylcholine. The results suggest that polypeptide transport across Caco-2 monolayers does not depend on lipophilicity, but that the facilitated transport does depend on the lipophilicity.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 29 条
  • [1] EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .8. EFFECTS OF SODIUM DODECYL-SULFATE ON CELL-MEMBRANE AND TIGHT JUNCTION PERMEABILITY IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
    ANDERBERG, EK
    ARTURSSON, P
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (04) : 392 - 398
  • [2] SODIUM CAPRATE ELICITS DILATATIONS IN HUMAN INTESTINAL TIGHT JUNCTIONS AND ENHANCES DRUG ABSORPTION BY THE PARACELLULAR ROUTE
    ANDERBERG, EK
    LINDMARK, T
    ARTURSSON, P
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (06) : 857 - 864
  • [3] CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
    ARTURSSON, P
    KARLSSON, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) : 880 - 885
  • [4] MONOMERIC INSULINS OBTAINED BY PROTEIN ENGINEERING AND THEIR MEDICAL IMPLICATIONS
    BRANGE, J
    RIBEL, U
    HANSEN, JF
    DODSON, G
    HANSEN, MT
    HAVELUND, S
    MELBERG, SG
    NORRIS, F
    NORRIS, K
    SNEL, L
    SORENSEN, AR
    VOIGT, HO
    [J]. NATURE, 1988, 333 (6174) : 679 - 682
  • [5] METABOLISM OF TESTOSTERONE DURING INVITRO TRANSPORT ACROSS CACO-2 CELL MONOLAYERS - EVIDENCE FOR BETA-HYDROXYSTEROID DEHYDROGENASE-ACTIVITY IN DIFFERENTIATED CACO-2 CELLS
    BUUR, A
    MORK, N
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (10) : 1290 - 1294
  • [6] THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS
    CONRADI, RA
    HILGERS, AR
    HO, NFH
    BURTON, PS
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (12) : 1453 - 1460
  • [7] THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS .2. PEPTIDE-BOND MODIFICATION WHICH RESULTS IN IMPROVED PERMEABILITY
    CONRADI, RA
    HILGERS, AR
    HO, NFH
    BURTON, PS
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (03) : 435 - 439
  • [8] GILL IJ, 1994, INT J PHARM, V1, P237
  • [9] DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS .2. ABSORPTION ENHANCER EFFECTS OF LYSOPHOSPHATIDYLCHOLINES
    HOVGAARD, L
    BRONDSTED, H
    NIELSEN, HM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 114 (02) : 141 - 149
  • [10] HOVGAARD L, 1994, UNPUB PHARM RES